S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged

Jack Henry & Associates (JKHY) Stock Forecast & Price Target

$165.60
+0.83 (+0.50%)
(As of 04/19/2024 08:50 PM ET)

Jack Henry & Associates Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 14 Analyst Ratings

Analysts' Consensus Price Target

$172.42
4.12% Upside
High Forecast$186.00
Average Forecast$172.42
Low Forecast$140.00
TypeCurrent Forecast
4/23/23 to 4/22/24
1 Month Ago
3/24/23 to 3/23/24
3 Months Ago
1/23/23 to 1/23/24
1 Year Ago
4/23/22 to 4/23/23
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
3 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
7 Hold rating(s)
7 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$172.42$170.92$169.54$177.40
Predicted Upside4.12% Upside9.49% Upside9.22% Upside7.80% Upside
Get Jack Henry & Associates Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for JKHY and its competitors with MarketBeat's FREE daily newsletter.

JKHY Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

JKHY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Jack Henry & Associates Stock vs. The Competition

TypeJack Henry & AssociatesComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.36
2.58
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside4.12% Upside114.41% Upside11.96% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/17/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$180.00 ➝ $186.00+12.88%
3/26/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetIn-Line ➝ In-Line$157.00 ➝ $172.00+2.64%
3/7/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoveragePeer Perform
2/8/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector Perform ➝ Sector Perform$161.00 ➝ $181.00+5.08%
2/7/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform
1/18/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$177.00+6.78%
12/6/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$167.00 ➝ $186.00+15.29%
10/20/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral ➝ Neutral$165.00+14.06%
10/18/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$180.00 ➝ $168.00+13.34%
10/12/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Sell$165.00 ➝ $140.00-4.88%
9/27/2023DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$174.00+17.93%
9/18/2023Northcoast Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$185.00+19.75%
8/17/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$165.00 ➝ $162.00+3.53%
8/17/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$200.00 ➝ $173.00+10.56%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 02:16 AM ET.

JKHY Price Target - Frequently Asked Questions

What is Jack Henry & Associates's consensus rating and price target?

According to the issued ratings of 14 analysts in the last year, the consensus rating for Jack Henry & Associates stock is Hold based on the current 1 sell rating, 7 hold ratings and 6 buy ratings for JKHY. The average twelve-month price prediction for Jack Henry & Associates is $172.42 with a high price target of $186.00 and a low price target of $140.00. Learn more on JKHY's analyst rating history.

Do Wall Street analysts like Jack Henry & Associates more than its competitors?

Analysts like Jack Henry & Associates less than other Computer and Technology companies. The consensus rating for Jack Henry & Associates is Hold while the average consensus rating for computer and technology companies is Moderate Buy. Learn more on how JKHY compares to other companies.

Does Jack Henry & Associates's stock price have much upside?

According to analysts, Jack Henry & Associates's stock has a predicted upside of 9.66% based on their 12-month stock forecasts.

What analysts cover Jack Henry & Associates?

Jack Henry & Associates has been rated by Evercore ISI, Robert W. Baird, Royal Bank of Canada, William Blair, and Wolfe Research in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:JKHY) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners